CogniCurrent Icon

COGNICURRENT

A compact global news feed for the bigger picture.

⌕
Regions
Topics
Saved views:
Save your current filters to revisit or share.
1 stories
🇧🇷 Folha (PT)
National & Local

Know the risks of retatrutida, a weight loss pen still in study phase

The article discusses the risks associated with the use of retatrutida, a weight loss pen not yet approved for use in any country and currently under clinical study.

Feb 20 • 10:00 UTC

Story in context

Loading Intelligence...

📡

Select a report from the feed to view analysis and related coverage.